A case of cellulitis complicating Campylobacter jejuni subspecies jejuni bacteremia and review of the literature

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 23, Issue 9, 2004, Pages 718-721

  Monselise, A ^a   Blickstein, D ^a   Ostfeld, I ^a   Segal, R ^a   Weinberger, M ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; NORFLOXACIN; TIMENTIN;

AGE DISTRIBUTION; AGED; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL INFECTION; CAMPYLOBACTER JEJUNI; CAMPYLOBACTER JEJUNI SUBSPECIES JEJUNI; CASE REPORT; CELLULITIS; CLINICAL FEATURE; DIARRHEA; DISEASE COURSE; GASTROENTERITIS; HUMAN; IMMUNE DEFICIENCY; INDUSTRIALIZATION; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW;

AGED; BACTEREMIA; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CELLULITIS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MYELODYSPLASTIC SYNDROMES; RECURRENCE; RISK ASSESSMENT; ROXITHROMYCIN; SEVERITY OF ILLNESS INDEX; THIENAMYCINS; TREATMENT OUTCOME;

EID: 4644258017     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-004-1201-x     Document Type: Review

References (25)

1. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe RV (1999) Food-related illness and death in the United States. Emerg Infect Dis 5:607-625
2. Allos BM (2001) Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 32:1201-1206
3. Blaser MJ (2000) Campylobacter jejuni and related species. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas and Bennett's principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 2276-2285
4. Schonheyder HC, Sogaard P, Frederiksen W (1995) A survey of Campylobacter bacteremia in three Danish counties, 1989 to 1994. Scand J Infect Dis 27:145-148
5. Lu PL, Hsueh PR, Hung CC, Chang SC, Luh KT, Lee CY (2000) Bacteremia due to Campylobacter species: high rate of resistance to macrolide and quinolone antibiotics. J Formos Med Assoc 99:612-617
6. Pigrau C, Bartolome R, Almirante B, Planes AM, Gavalda J, Pahissa A (1997) Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis 25:1414-1420
7. Tee W, Mijch A (1998) Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. Clin Infect Dis 26:91-96
8. Font C, Cruceta A, Moreno A, Miro O, Coll-Vinent B, Almela M, Mensa J (1997) A study of 30 patients with bacteremia due to Campylobacter spp. Med Clin (Barc) 108:336-340
9. Skirrow MB, Jones DM, Sutcliffe E, Benjamin J (1993) Campylobacter bacteraemia in England and Wales, 1981-91. Epidemiol Infect 110:567-573
10. Spelman DW, Davidson N, Buckmaster ND, Spicer WJ, Ryan P (1986) Campylobacter bacteraemia: a report of 10 cases. Med J Aust 145:503-505
11. Francioli P, Herzstein J, Grob JP, Vallotton JJ, Mombelli G, Glauser MP (1985) Campylobacter fetus subspecies fetus bacteremia. Arch Intern Med 145:289-292
12. LeBar WD, Menard RR, Check FE (1985) Hypogammaglobulinemia and recurrent Campylobacter jejuni infection. J Infect Dis 152:1099-1100
13. Kerstens PJ, Endtz HP, Meis JF, Oyen WJ, Koopman RJ, van den Broek PJ, van der Meer JW (1992) Erysipelas-like skin lesions associated with Campylobacter jejuni septicemia in patients with hypogammaglobulinemia. Eur J Clin Microbiol Infect Dis 11:842-847
14. Musher DM (1980) Cutaneous and soft-tissue manifestations of sepsis due to gram-negative enteric bacilli. Rev Infect Dis 2:854-866
15. Righter J, Wells WA, Hart GD, McNeely DJ (1983) Relapsing septicemia caused by Campylobacter fetus subsp. fetus. Can Med Assoc J 128:686-689
16. Carbone KM, Heinrich MC, Quinn TC (1985) Thrombophlebitis and cellulitis due to Campylobacter fetus ssp. fetus. Report of four cases and a review of the literature. Medicine (Baltimore) 64:244-250
17. Neuzil KM, Wang E, Haas DW, Blaser MJ (1994) Persistence of Campylobacter fetus bacteremia associated with absence of opsonizing antibodies. J Clin Microbiol 32:1718-1720
18. Ichiyama S, Hirai S, Minami T, Nishiyama Y, Shimizu S, Shimokata K, Ohta M (1998) Campylobacter fetus subspecies fetus cellulitis associated with bacteremia in debilitated hosts. Clin Infect Dis 27:252-255
19. Briedis DJ, Khamessan A, McLaughlin RW, Vali H, Panaritou M, Chan ECS (2002) Isolation of Campylobacter fetus subsp. fetus from a patient with cellulitis. J Clin Microbiol 40:4792-4796
20. Engberg J, Aarestrup FM, Taylor DE, Gerner-Smidt P, Nachamkin I (2001) Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis 7:24-34
21. Wang WL, Blaser MJ (1986) Detection of pathogenic Campylobacter species in blood culture systems. J Clin Microbiol 23:709-714
22. Tajada P, Gomez-Graces JL, Alos JI, Balas D, Cogollos R (1996) Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors. Antimicrob Agents Chemother 40:1924-1925
23. Tremblay C, Gaudreau C (1998) Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus. Antimicrob Agents Chemother 42:1847-1849
24. Lau SK, Woo PC, Leung KW, Yuen KY (2002) Emergence of cotrimoxazole- and quinolone-resistant Campylobacter infections in bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 21:127-129
25. Blaser MJ (1998) Campylobacter fetus-emerging infection and model system for bacterial pathogenesis at mucosal surfaces. Clin Infect Dis 27:256-258